A detailed history of Willis Investment Counsel transactions in Abb Vie Inc. stock. As of the latest transaction made, Willis Investment Counsel holds 1,141 shares of ABBV stock, worth $205,380. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,141
Holding current value
$205,380
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $186,941 - $227,435
1,141 New
1,141 $225,000
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $182,354 - $207,776
1,141 New
1,141 $207,000
Q1 2023

Mar 07, 2024

BUY
$144.61 - $166.54 $187,125 - $215,502
1,294 New
1,294 $206,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $187,125 - $215,502
1,294 New
1,294 $206,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Willis Investment Counsel Portfolio

Follow Willis Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Willis Investment Counsel with notifications on news.